MedMira (MIR.V) has a profit margin of -730.36%, below the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2026
Trailing 12 months ending Apr 2026
The latest profit margin for MIR.V is -730.36% as of April 2026. That compares with -1832.05% in the prior-year period — up 60.1% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside MedMira's historical trend and sector peers before judging valuation or financial health.
Over the past year, MIR.V's profit margin moved from -1832.05% to -730.36% — a 60.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedMira's valuation or profitability profile.
Against Healthcare companies, MIR.V currently prints -730.36% for profit margin, while the sector average sits near 10.58%. That is roughly 7002.9% below the sector mean. Large gaps often invite a closer look at MedMira's growth, margins, and balance sheet.
Profit Margin shows how effectively MedMira converts resources into returns. At -730.36%, MIR.V may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1832.05% in the prior-year period — up 60.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MIR.V's profit margin (-730.36%), review year-over-year change from -1832.05%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.